Tamarack Capital Management, LLC has released its quarterly 13F report. We will review top three stocks from the fund’s latest portfolio in this article. Tamarack Fund’s best position in the latest filing is in Endologix, Inc. (NASDAQ:ELGX), Spectranetics Corp (NASDAQ:SPNC) and Medtronic, Inc. (NYSE:MDT).
Tamarack Capital Management’s latest filing depicts that the fund has 33,00000 shares of Endologix, Inc. (NASDAQ:ELGX) which worth around $34 million. As of the last quarter, the fund had 2375000 shares of the company worth around $33 million. Therefore, the fund has depleted its holding on the stock minutely. Among other shareholders of Endologix, Inc. (NASDAQ:ELGX) is Stuart Weisbrod’s Iguana Healthcare Management. The stock recorded its last purchase and sale in the last week. Thomas Wilder sold Endologix, Inc. (NASDAQ:ELGX) stock at an average share price of $13.
Spectranetics Corp (NASDAQ:SPNC) is the second biggest position held by Tamarack Capital Management. The fund has 1150000 shares of the company which worth $30 million. In the last quarter, the fund had the same number of shares, but the worth was around $26 million. Among other shareholders of this company is David Kim’s Ghost Tree Capital. Spectranetics Corp (NASDAQ:SPNC) recorded its last purchase back in 2012. The stock was sold by M Joseph Ruggio at an average price of $31.
Medtronic, Inc. (NYSE:MDT) is the third biggest position held by the fund. According to the latest filing, it has 370,000 shares of the company worth around $22 million. As of the last quarterly filing, the fund had no equity holding of Medtronic, Inc. (NYSE:MDT) Robert Sanborn’s Sanborn Kilcollin Partners is one of the famous shareholders of Medtronic, Inc. (NYSE:MDT). The company’s stock was purchased back in 2013. It was sold in September this year at $64 price per share.
Suggested Articles:
